Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Gufic Bio
Gufic Bio
BSE: 509079NSE: GUFICBIOISIN: INE742B01025

20th-Aug-2019 16:46Source: BSE

Gufic Biosciences - Outcome of Board Meeting

The Board of Directors of the Company at its Meeting held on August 20, 2019, which commenced at 3.00 p.m and concluded at 4.30 p.m, inter alia considered and approved the following:

1. Recommended Dividend @ 5% i.e Re. 0.05 per Equity share (Face Value of Re.1/- each) for the year ended March 31, 2019, subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company.

Sections
Follow us on
Available On
PCI DSS Compliant